Zimmer Biomet – Hot or Not

PUBLISHED: Fri, 18 Aug 2017 05:01:30 GMT
Share


Zimmer Biomet designs, manufactures and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products. It has a market cap of $ 22.8billion. Has a PE of 32.27, dividend yield of 0.85 per cent. Guest Nicholas Sorour, Sasfin Wealth and resident expert Paul Theron from Vestact decide whether Zimmer Biomet hot or not.

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.